SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-18-042374
Filing Date
2018-02-13
Accepted
2018-02-13 15:37:03
Documents
2
Group Members
DAG VENTURES MANAGEMENT V, LLCDAG VENTURES V, L.P.JOHN J. CADEDDUR. THOMAS GOODRICH

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d503497dsc13ga.htm SC 13G/A 110308
2 EX-99.1 d503497dex991.htm EX-99.1 6766
  Complete submission text file 0001193125-18-042374.txt   118758
Mailing Address 251 LYTTON AVENUE, SUITE 200 PALO ALTO CA 94304
Business Address 251 LYTTON AVENUE, SUITE 200 PALO ALTO CA 94304 (650) 543-8180
DAG Ventures V-QP, L.P. (Filed by) CIK: 0001520911 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 18602886
SIC: 2836 Biological Products, (No Diagnostic Substances)